期刊文献+

右小腿腺泡状软组织肉瘤一例

Alveolar soft part sarcoma in the right lower extremity: a case report
下载PDF
导出
摘要 腺泡状软组织肉瘤(ASPS)是一种罕见的高度恶性软组织肿瘤。该文报道了1例罕见的ASPS,患者为男性、17岁,肿瘤发生于右小腿深部软组织。镜下肿瘤呈实性生长,腺泡结构消失,被纤维组织分隔,并且有大量血窦形成,血管内可见瘤栓,胞质内可见棒状结晶体。免疫组织化学染色示转录因子3(TFE3)核阳性,SMA部分阳性,F8部分阳性,Vimentin少数散在阳性,过碘酸-雪夫染色阳性,余指标均阴性。扩大切除肿物后,患者14个月无瘤存活。该例提示,结合临床、组织学形态及免疫组织化学检测,可以对ASPS做出正确诊断,ASPS的鉴别诊断需排除血窦丰富、血管周源性或胞浆嗜伊红、透亮的肿瘤,TFE3是其诊断的特异性标志物。 Alveolar soft part sarcoma( ASPS) is a rare highly malignant soft tissue neoplasm. In this article,we reported one 17-year old male patient diagnosed with ASPS in the deep soft tissues of his right lower extremity. Microscopically,the neoplasm was manifested with solid texture,loss of alveolar structure and separated by fibrovascular septa. A large quantity of blood sinus was observed and tumor thrombosis was identified within the blood vessels. Needle-like crystals were detected in the cytoplasm of tumor cells. Immunohistochemical staining revealed that the tumor cells were positive for TFE3 nucleus,partially positive for SMA,partially positive for F8,dispersely positive for Vimentin,positive for Periodic acid-Schiff staining and negative for alternative parameters. After enlarged tumor resection,the tumor-free survival of the patient achieved 14 months.This case prompts that combined application of clinical,histological and morphological characteristics and immunohistochemical examinations contributes to accurate diagnosis of ASPS. Abundant blood sinus and perivascular or cytoplasmic eosin-stained transparent tumors should be excluded for the differential diagnosis of ASPS.TFE3 is a specific biomarker.
出处 《新医学》 2017年第2期132-136,共5页 Journal of New Medicine
关键词 腺泡状软组织肉瘤 病理诊断 鉴别诊断 治疗 预后 Alveolar soft part sarcoma Pathological diagnosis Differential diagnosis Treatment Prognosis
  • 相关文献

参考文献3

二级参考文献60

  • 1甄平,刘兴炎,文益民.腺泡状软组织肉瘤多发骨转移一例报告[J].中华骨科杂志,1996,16(6):403-404. 被引量:2
  • 2Pappo AS, Shapiro DN, Crist WM, et al. Biology and therapy of pediatric rhabdomyosarcoma. J Clin Oncol, 1995, 13: 2123-2139.
  • 3Crist WM, Anderson JR, Meza JL, et al. Intergroup rhabdomyosareoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol, 2001, 19: 3091- 3102.
  • 4Maurer HM, Gehan EA, Beltangady M, et al. The In- tergroup rhabdomyosarcoma study-Ⅱ. Cancer, 1993, 71 : 1904-1922.
  • 5Williamson D, Missiaglia E, de Reynies A, et al. Fu- sion gene-negative alveolar rhabdomyosarcoma is clinical- ly and molecularly indistinguishable from embryonal rhabdomyosarcoma. J Clin Oncol, 2010, 28: 2151- 2158.
  • 6Van Gaal JC, Flucke UE, Roeffen MH, et al. Anaplas- tic lymphoma kinase aberrations in rhabdomyosarcoma: clinical and prognostic implications. J Clin Oncol,2012, 30: 308-315.
  • 7Joshi D, Anderson JR, Paidas C, et al. Age is an inde- pendent prognostic factor in rhabdomyosarcoma: a report from the soft tissue sarcoma committee of the Children's oncology group. Pediatr Blood Cancer, 2004, 42: 64- 73.
  • 8Raney RB, Waherhouse DO, Meza JL, et al. Results of the Intergroup rhabdomyosarcoma study group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhab- domyosarcoma: a report from the soft tissue sarcoma committee of the children's oncology group. J Clin On- col. 2011,29: 1312-1318.
  • 9Walterhouse D, Pappo AS, Meza JL, et al. Shorter du- ration therapy that includes vincristine (V), daetinomy- cin (A), and lower doses of cyclophosphamide (C) with or without radiation therapy for patients with newly diagnosed low-risk embryonal rhabdomyosarcoma (ERMS) : A report from the Children's Oncology Group (COG). J Clin Oncol, 2011, 29 (abstr 9516).
  • 10Arndt CA, Stoner JA, Hawkins DS, et al. Vncristine, actinomycin, and cyclophosphamide compared with vin- cristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803. J Clin Oncol, 2009, 27: 5182- 5188.

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部